2-Oxo-2H-chromen-3-yl propanoate

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 香豆素及其衍生物
• 英文名称: 2-Oxo-2H-chromen-3-yl propanoate
• 英文别名: (2-oxochromen-3-yl) propanoate
• 化学式: C₁₂H₁₀O₄
• 分子量: 218.2
• InChiKey: FHPBPWSHRHEAJF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE
  申请人：Kubota Yusuke

  公开号：US20130334461A1

  公开（公告）日：2013-12-19

  Provided are a polymerizable liquid crystal composition, a coating material, a medium, and a polarizing device each produced using a polymerizable liquid crystal compound and a colorant and each capable of producing polarized light suitable for polarizing devices, and also a novel naphtholactam derivative, a novel coumarin derivative, a novel Nile Red derivative, and a novel anthracene derivative each suitable for use as the colorant. Specifically provided are a polymerizable liquid crystal composition containing (A) at least one liquid crystal compound having a polymerizable functional group, (B) at least one colorant, and (C) a polymerization initiator, and a novel naphtholactam derivative of formula (IV′), a novel coumarin derivative of formula (VI′), a novel Nile Red derivative of formula (VII′), and a novel anthracene derivative of formula (VIII′) each suitable for use as the colorant (B).

  提供了一种可聚合的液晶组合物、涂料材料、介质和极化装置，每种都使用了聚合液晶化合物和颜料，并且能够产生适合于极化装置的偏振光，还提供了一种新型萘内酰胺衍生物、一种新型香豆素衍生物、一种新型尼罗红衍生物和一种新型蒽衍生物，每种都适用于用作颜料。具体提供了一种聚合液晶组合物，包含（A）至少一种具有聚合功能基团的液晶化合物，（B）至少一种颜料，和（C）聚合引发剂，以及一种适用于用作颜料（B）的新型萘内酰胺衍生物（IV′）, 一种新型香豆素衍生物（VI′）, 一种新型尼罗红衍生物（VII′）和一种新型蒽衍生物（VIII′）。
• PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE
  申请人：Bristol-Myers Squibb Pharma Company

  公开号：EP1196436A2

  公开（公告）日：2002-04-17
• POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE, NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE
  申请人：DIC Corporation

  公开号：EP2695930B1

  公开（公告）日：2019-09-11
• US9475991B2
  申请人：——

  公开号：US9475991B2

  公开（公告）日：2016-10-25
• [EN] PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE<br/>[FR] INHIBITEURS DE LA PROTEASE DU VIRUS DE L'HEPATITE C A BASE D'ACIDE BORONIQUE PEPTIDE
  申请人：DU PONT PHARM CO

  公开号：WO2001002424A2

  公开（公告）日：2001-01-11

  The present invention relates generally to novel α-aminoboronic acids and corresponding peptide analogs represented by structural Formula (I) or pharmaceutically acceptable salt forms thereof, wherein R?1, R2, R3, Y1, Y2¿, and A are described herein. The invention is also concerned with pharmaceutical formulations comprising these novel compounds as active ingredients and the use of the novel compounds and their formulations in the treatment of hepatitis C viral infections. The compounds of the invention are inhibitors of hepatitis C viral protease.